News - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

151 to 175 of 2221 results

Oxford BioTherapeutics uses Amgen’s Xenomouse antibodies for breast cancer

07-05-2014

UK biotech company Oxford BioTherapeutics has obtained the exclusive global rights to USA-based Amgen’s…

AmgenBiotechnologyImmunoGenLicensingOncologyOxford BioTherapeutics

Eleven Biotherapeutics presents positive data on eye disease candidates

07-05-2014

US-based Eleven Biotherapeutics, a clinical-stage biopharmaceutical company developing protein therapeutics…

BiologyBiopharmaceutical company developing protein therapeuticsBiotechnologyCytokinesHealth Medical PharmaMedicineOphthalmicsResearchUSA

Rolf Stahel joins Ergomed as Non-Executive Chairman

Rolf Stahel joins Ergomed as Non-Executive Chairman

07-05-2014

UK-based drug development services company Ergomed has announced the appointment of Rolf Stahel to its…

BiotechnologyBoardroomErgomed Clinical ResarchPharmaceuticalUKUSA

Cobra Biologics appoints Daniel Smith as CSO

Cobra Biologics appoints Daniel Smith as CSO

07-05-2014

Cobra Biologics is pleased to announce the appointment of Daniel Smith as Chief Scientific Officer with…

BiotechnologyBoardroomCobra BiologicsUK

US priority review for Astellas and Medivation’s sNDA for prostate cancer

US priority review for Astellas and Medivation’s sNDA for prostate cancer

06-05-2014

Japanese drug major Astellas' US subsidiary and Medivation revealed that the US Food and Drug Administration…

Astellas PharmaBiotechnologyMedivationOncologyRegulationUSAXtandi

Janssen establishes innovative public-private consortium for inflammatory bowel disease research

Janssen establishes innovative public-private consortium for inflammatory bowel disease research

06-05-2014

Janssen Research & Development, a unit of US health care giant Johnson & Johnson has established a Cooperative…

BiotechnologyGastro-intestinalsJanssenJohnson & JohnsonResearch

Cytos Biotech to wind down key operational activities

05-05-2014

Switzerland-based Cytos Biotechnology has entered into agreements with major creditors resulting in a…

BiotechnologyCYT003Cytos BiotechnologyFinancialLicensingRespiratory and Pulmonary

Gilead’s Sovaldi shows “indication of added benefit for specific patients,” says IQWiG

Gilead’s Sovaldi shows “indication of added benefit for specific patients,” says IQWiG

03-05-2014

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products (AMNOG),…

Anti-viralsBiotechnologyGermanyGilead SciencesPricingSovaldi

FDA issues CRL over Acorda's Plumiaz marketing application

FDA issues CRL over Acorda's Plumiaz marketing application

02-05-2014

There was disappointment for US biotech firm Acorda Therapeutics, which says it has received a complete…

Acorda TherapeuticsBiotechnologyNeurologicalPlumiazRegulationUSA

Sally Adams to join Scancell as Development Director

Sally Adams to join Scancell as Development Director

01-05-2014

UK-based cancer therapeutics firm Scancell has announced the appointment of Sally Adams to the board…

BiotechnologyBoardroomScancellUK

Midatech appoints new chairman and chief medical officer

Midatech appoints new chairman and chief medical officer

01-05-2014

UK nanotechnology firm Midatech has announced the appointments of Rolf Stahel as chairman and Craig Cook…

BiopharmaceuticalBiotechnologyBoardroomChief operating officerDrug discoveryMidatechPharmaceuticalStahelUnited KingdomUSA

Bristol-Myers acquires iPierian for $175 million upfront, plus $550 possible milestones

Bristol-Myers acquires iPierian for $175 million upfront, plus $550 possible milestones

30-04-2014

US pharma major Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused…

BiotechnologyBristol-Myers SquibbiPierianIPN007Mergers & AcquisitionsNeurological

Ambrx and Zhejiang Hisun sign deal over cancer treatment

Ambrx and Zhejiang Hisun sign deal over cancer treatment

30-04-2014

USA-based clinical-stage biopharmaceutical company Ambrx and Chinese pharma firm Zhejiang Hisun Pharmaceutical…

AmbrxBiopharmaceuticalBiotechnologyBusiness FinanceChinaHealth Medical PharmaHealth Medical PharmaLicensingOncologyPharmaceutical industryUSA

Amicus Thera leaps on positive migalastat results

29-04-2014

US biotech firm Amicus Therapeutics (has released positive 12- and 24-month data from its first Phase…

Amicus TherapeuticsBiotechnologymigalastatRare diseasesResearch

Athersys disappointed by Phase II MultiStem study results in UC

29-04-2014

US biotech firm Athersys has announced that interim results from the Phase II clinical study of its MultiStem…

AthersysBiotechnologyChronic, moderate-to-severe UCClinical researchGenito-urinaryHealthMedicineRefractory ulcerative colitisResearchUSA

Nanobiotix appoints Thierry Otin as Head of Manufacturing and Supply

Nanobiotix appoints Thierry Otin as Head of Manufacturing and Supply

29-04-2014

French nanomedicine company Nanobiotix has announced the appointment of Thierry Otin as Head of Manufacturing…

BiotechnologyBoardroomFranceNanobiotix

Transgene seeks partner for TG4010 as Novartis opts out

29-04-2014

There was disappointing news for French biotech firm Transgene today, when it received notification from…

BiotechnologyLicensingNovartisOncologyTransgene

Merck & Co enters deal with Agenus worth a potential $100 million in milestones

Merck & Co enters deal with Agenus worth a potential $100 million in milestones

28-04-2014

USA-based biotech firm Agenus has entered into a collaboration and license agreement with pharma giant…

AgenusBiotechnologyLicensingMerck & CoOncologyResearch

Coherus Biosciences appoints Michael Fleming as Senior Vice President, Commercial Strategy

Coherus Biosciences appoints Michael Fleming as Senior Vice President, Commercial Strategy

28-04-2014

US biopharmaceutical company Coherus Biosciences has announced the appointment of Michael Fleming as…

BiotechnologyBoardroomCoherus BioSciencesPharmaceuticalUSA

Janssen’s Vokanamet approved in EU for adults with type 2 diabetes

28-04-2014

The European Commission has approved US health care giant Johnson & Johnson subsidiary Janssen-Cilag’s…

BiotechnologyDiabetesEuropeJanssen-CilagJohnson & JohnsonRegulationVokanamet

151 to 175 of 2221 results

Back to top